Dillon & Associates Inc Abbott Laboratories Transaction History

Dillon & Associates Inc

  • $711 Million
  • Q3 2024

A detailed history of Dillon & Associates Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Dillon & Associates Inc holds 210,347 shares of ABT stock, worth $24.2 Million. This represents 3.37% of its overall portfolio holdings.

Number of Shares
210,347
Previous 205,983 2.12%
Holding current value
$24.2 Million
Previous $21.4 Million 11.94%
% of portfolio
3.37%
Previous 3.11%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$100.07 - $118.13 $436,705 - $515,519
4,364 Added 2.12%
210,347 $24 Million
Q2 2024

Aug 06, 2024
BUY
$100.73 - $112.44 $1.4 Million - $1.56 Million
13,881 Added 7.23%
205,983 $21.4 Million
Q1 2024

Apr 30, 2024
SELL
$109.52 - $120.96 $33,294 - $36,771
-304 Reduced 0.16%
192,102 $21.9 Million
Q4 2023

Feb 08, 2024
SELL
$90.19 - $110.4 $365,900 - $447,892
-4,057 Reduced 2.07%
192,406 $21.2 Million
Q3 2023

Nov 13, 2023
SELL
$95.53 - $114.62 $7,546 - $9,054
-79 Reduced 0.04%
196,463 $19.1 Million
Q2 2023

Aug 08, 2023
SELL
$100.78 - $112.29 $652,449 - $726,965
-6,474 Reduced 3.19%
196,542 $21.4 Million
Q1 2023

May 02, 2023
SELL
$96.86 - $114.01 $555,782 - $654,189
-5,738 Reduced 2.75%
203,016 $20.5 Million
Q1 2023

May 01, 2023
BUY
$96.86 - $114.01 $295,035 - $347,274
3,046 Added 1.48%
208,754 $21.1 Million
Q4 2022

Feb 06, 2023
SELL
$95.06 - $111.52 $46,579 - $54,644
-490 Reduced 0.24%
205,708 $22.6 Million
Q3 2022

Nov 08, 2022
BUY
$96.76 - $112.03 $36,091 - $41,787
373 Added 0.18%
206,198 $20 Million
Q2 2022

Jul 26, 2022
SELL
$102.07 - $123.37 $9,900 - $11,966
-97 Reduced 0.05%
205,825 $22.4 Million
Q1 2022

May 06, 2022
SELL
$114.02 - $139.04 $322,904 - $393,761
-2,832 Reduced 1.36%
205,922 $24.3 Million
Q4 2021

Feb 14, 2022
BUY
$115.53 - $141.46 $10,051 - $12,307
87 Added 0.04%
208,754 $29.4 Million
Q3 2021

Oct 28, 2021
BUY
$116.66 - $129.06 $63,813 - $70,595
547 Added 0.26%
208,667 $24.6 Million
Q2 2021

Aug 02, 2021
SELL
$105.79 - $124.53 $46,124 - $54,295
-436 Reduced 0.21%
208,120 $24.1 Million
Q1 2021

May 10, 2021
SELL
$108.84 - $128.23 $287,664 - $338,911
-2,643 Reduced 1.25%
208,556 $25 Million
Q4 2020

Feb 12, 2021
SELL
$105.0 - $114.42 $299,775 - $326,669
-2,855 Reduced 1.33%
211,199 $23 Million
Q3 2020

Nov 06, 2020
SELL
$91.64 - $111.29 $93,197 - $113,181
-1,017 Reduced 0.47%
214,054 $23.3 Million
Q2 2020

Jul 28, 2020
SELL
$76.57 - $98.0 $38,208 - $48,902
-499 Reduced 0.23%
215,071 $19.6 Million
Q1 2020

May 07, 2020
BUY
$62.82 - $91.86 $254,106 - $371,573
4,045 Added 1.91%
215,570 $17 Million
Q4 2019

Feb 03, 2020
BUY
$78.51 - $87.4 $44,672 - $49,730
569 Added 0.27%
211,525 $18.4 Million
Q3 2019

Oct 25, 2019
SELL
$81.84 - $88.74 $2,864 - $3,105
-35 Reduced 0.02%
210,956 $17.7 Million
Q2 2019

Jul 22, 2019
BUY
$72.88 - $85.0 $176,223 - $205,530
2,418 Added 1.16%
210,991 $17.7 Million
Q1 2019

May 07, 2019
SELL
$66.22 - $80.06 $16,886 - $20,415
-255 Reduced 0.12%
208,573 $16.7 Million
Q4 2018

Feb 14, 2019
SELL
$65.56 - $74.27 $87,194 - $98,779
-1,330 Reduced 0.63%
208,828 $15 Million
Q3 2018

Nov 14, 2018
BUY
$60.81 - $73.36 $119,187 - $143,785
1,960 Added 0.94%
210,158 $15.3 Million
Q2 2018

Aug 08, 2018
SELL
$57.57 - $63.54 $38,399 - $42,381
-667 Reduced 0.32%
208,198 $12.7 Million
Q1 2018

May 08, 2018
BUY
$56.27 - $63.62 $47,266 - $53,440
840 Added 0.4%
208,865 $12.5 Million
Q4 2017

Feb 08, 2018
SELL
$53.68 - $57.47 $98,180 - $105,112
-1,829 Reduced 0.87%
208,025 $11.9 Million
Q3 2017

Nov 13, 2017
BUY
$48.06 - $53.64 $103,232 - $115,218
2,148 Added 1.03%
209,854 $11.1 Million
Q2 2017

Aug 09, 2017
BUY
N/A
207,706
207,706 $10.2 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Dillon & Associates Inc Portfolio

Follow Dillon & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email